Skip to main content

Table 3 Body weight and risk factors for metabolic disease changes during the 12-week study

From: Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial

 Control(n = 79)ADF(n = 90)TRF(n = 95)P-value
 Week 4Week 12Week 4Week 12Week 4Week 12Week 4Week 12
Body weight (kg)70.32 ± 6.7571.77 ± 6.9070.76 ± 7.7671.28 ± 7.0271.31 ± 7.0471.67 ± 7.370.6480.709
BMI26.48 ± 1.6026.64 ± 1.6625.97 ± 1.7526.15 ± 1.5826.48 ± 1.3826.60 ± 1.460.0490.071
Fat mass (kg)27.91 ± 3.5328.01 ± 3.4927.09 ± 2.5227.10 ± 2.5227.36 ± 3.4427.65 ± 3.340.2410.165
Lean mass (kg)42.41 ± 7.2842.71 ± 7.6743.67 ± 7.6144.17 ± 7.7943.96 ± 7.1844.04 ± 7.470.3520.395
Waist circumference88.29 ± 4.7388.54 ± 5.1088.99 ± 5.2087.19 ± 4.8889.70 ± 7.4287.58 ± 4.390.5900.174
Cholesterol (mg/dL)4.45 ± 1.364.65 ± 1.363.95 ± 1.084.15 ± 1.064.03 ± 1.554.37 ± 1.530.0390.055
Total Direct HDL(mg/dL)1.29 ± 0.551.18 ± 0.511.28 ± 0.411.17 ± 0.381.18 ± 0.471.15 ± 0.450.2060.920
LDL (mg/dL)2.55 ± 0.792.51 ± 0.762.82 ± 0.852.79 ± 0.832.73 ± 0.882.71 ± 0.870.1010.085
Triglycerides (mg/dL)2.28 ± 1.702.40 ± 1.702.21 ± 1.912.12 ± 1.902.27 ± 1.752.31 ± 1.750.9650.582
Glucose (mg/dL)5.18 ± 0.0724.94 ± 1.225.36 ± 1.325.19 ± 0.675.21 ± 1.065.05 ± 1.350.5000.355
Liver stiffness (kpa)18.39 ± 4.6418.36 ± 3.8418.03 ± 2.2518.05 ± 2.8418.13 ± 4.1118.37 ± 3.650.8250.766